by bureau Peppr | 10 February, 2021 | News
With the EU and US GMP capabilities from our facility in Oss, BioConnection is proud to assist VarmX to accelerate the GMP manufacturing trajectory and bring VMX-C001 into clinical trials and ultimately to patients who currently have limited options to effective and...
by bureau Peppr | 23 December, 2020 | News
BioConnection announces that it is collaborating with AdaptVac for the Drug Product manufacture of their COVID-19 vaccine in its state-of-the-art-GMP manufacturing facility in the Netherlands. AdaptVac aims to accelerate the development of safe and efficacious...
by bureau Peppr | 22 June, 2020 | News
With our capabilities from our facility in Oss, the Netherlands, we are able to assist AIMM Therapeutics in the development of their groundbreaking clinical phase anti-cancer...
by bureau Peppr | 12 May, 2020 | News
BioConnection B.V. / Oss, The Netherlands BioConnection has sterile drug product production capacity available for COVID-19 programs BioConnection (established in 2005) is an independent CMO (Contract Manufacturing Organization). We have our own facility in Oss, The...
by bureau Peppr | 9 April, 2020 | News
BioConnection B.V. / Oss, The Netherlands / April 9, 2020 BioConnection has sterile production capacity available for the battle against the Covid-19 pandemic BioConnection (established in 2005) is an independent CMO (Contract Manufacturing Organization) in Oss, The...
